Breast Cancer | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of HER2-Positive Breast Cancer

Featuring perspectives from Drs. Carey Anders, Virginia Borges, Sara Hurvitz and Ian Krop, moderated by Dr. Lisa Carey, including the following topics: Considerations in the care of patients with HER2-positive localized breast cancer (BC) (0:00) Optimizing the management of HER2-positive metastatic BC (23:19) Treatment of HER2-positive brain metastases (45:57) Future directions in the management of HER2-positive localized and metastatic BC (1:11:00) Incidence and management of adverse events associated with HER2-targeted therapy (1:33:49) CME information and select publications